Civic Intelligence

Cure First

990EZ • Fiscal year 2017 • EIN 45-4721229

Jan 01, 2017 to Dec 31, 2017

Seattle, WA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

54th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

54th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Net Margin

67th percentile

12%

Higher net margin than 67% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2017

Asset Growth

85th percentile

51%

Faster asset growth than 85% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Revenue Growth

58th percentile

5.9%

Faster revenue growth than 58% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Assets

Up

$53,926

Up $18,204 (+51%) from 2016

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

Up

$147,311

Up $8,175 (+5.9%) from 2016

Expenses

Down

$129,107

Down $52,840 (-29%) from 2016

Net Income

Up

$18,204

Up $61,015 (+143%) from 2016

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100K$50K$0Assets 2013: $24,728Net Assets 2013: $24,7282013Assets 2015: $82,920Liabilities 2015: $4,387Net Assets 2015: $78,5332015Assets 2016: $35,722Net Assets 2016: $35,7222016Assets 2017: $53,926Liabilities 2017: $02017Assets 2018: $17,919Net Assets 2018: $17,9192018Assets 2019: $28,201Net Assets 2019: $28,2012019Assets 2020: $33,374Net Assets 2020: $33,3742020Assets 2021: $46,807Liabilities 2021: $02021Assets 2022: $65,135Liabilities 2022: $31,000Net Assets 2022: $34,1352022Assets 2023: $4,745Liabilities 2023: $31,0002023

Highlighted filing

2017

Assets$53,926
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2013: $16,234Expenses 2013: $6,015Net Income 2013: $10,2192013Revenue 2015: $121,800Expenses 2015: $43,939Net Income 2015: $77,8612015Revenue 2016: $139,136Expenses 2016: $181,947Net Income 2016: -$42,8112016Revenue 2017: $147,311Expenses 2017: $129,107Net Income 2017: $18,2042017Revenue 2018: $55,303Expenses 2018: $91,310Net Income 2018: -$36,0072018Revenue 2019: $33,455Expenses 2019: $23,173Net Income 2019: $10,2822019Revenue 2020: $12,259Expenses 2020: $7,086Net Income 2020: $5,1732020Revenue 2021: $14,724Expenses 2021: $1,291Net Income 2021: $13,4332021Revenue 2022: $12,135Expenses 2022: $24,807Net Income 2022: -$12,6722022Revenue 2023: $5,359Expenses 2023: $65,749Net Income 2023: -$60,3902023

Highlighted filing

2017

Revenue$147,311
Expenses$129,107
Net Income$18,204
Filing Detail Status

This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview

Mission

Cure first mission is to accelerate discovery of targeted and less toxic treatment for cancer using innovative technologies.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings